SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-084528
Filing Date
2022-03-25
Accepted
2022-03-25 07:11:05
Documents
49
Period of Report
2022-03-25
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d242555d8k.htm   iXBRL 8-K 26559
2 EX-99.1 d242555dex991.htm EX-99.1 62902
3 EX-99.2 d242555dex992.htm EX-99.2 41940
7 GRAPHIC g242555ex99_2p10g1.jpg GRAPHIC 201869
8 GRAPHIC g242555ex99_2p11g1.jpg GRAPHIC 317177
9 GRAPHIC g242555ex99_2p12g1.jpg GRAPHIC 269259
10 GRAPHIC g242555ex99_2p13g1.jpg GRAPHIC 224111
11 GRAPHIC g242555ex99_2p14g1.jpg GRAPHIC 285411
12 GRAPHIC g242555ex99_2p15g1.jpg GRAPHIC 277890
13 GRAPHIC g242555ex99_2p16g1.jpg GRAPHIC 385411
14 GRAPHIC g242555ex99_2p17g1.jpg GRAPHIC 270148
15 GRAPHIC g242555ex99_2p18g1.jpg GRAPHIC 134997
16 GRAPHIC g242555ex99_2p19g1.jpg GRAPHIC 332197
17 GRAPHIC g242555ex99_2p1g1.jpg GRAPHIC 217541
18 GRAPHIC g242555ex99_2p20g1.jpg GRAPHIC 195260
19 GRAPHIC g242555ex99_2p21g1.jpg GRAPHIC 356850
20 GRAPHIC g242555ex99_2p22g1.jpg GRAPHIC 213479
21 GRAPHIC g242555ex99_2p23g1.jpg GRAPHIC 255025
22 GRAPHIC g242555ex99_2p24g1.jpg GRAPHIC 260205
23 GRAPHIC g242555ex99_2p25g1.jpg GRAPHIC 257054
24 GRAPHIC g242555ex99_2p26g1.jpg GRAPHIC 262365
25 GRAPHIC g242555ex99_2p27g1.jpg GRAPHIC 329627
26 GRAPHIC g242555ex99_2p28g1.jpg GRAPHIC 251579
27 GRAPHIC g242555ex99_2p29g1.jpg GRAPHIC 182965
28 GRAPHIC g242555ex99_2p2g1.jpg GRAPHIC 550161
29 GRAPHIC g242555ex99_2p30g1.jpg GRAPHIC 280498
30 GRAPHIC g242555ex99_2p31g1.jpg GRAPHIC 239984
31 GRAPHIC g242555ex99_2p32g1.jpg GRAPHIC 219436
32 GRAPHIC g242555ex99_2p33g1.jpg GRAPHIC 258375
33 GRAPHIC g242555ex99_2p34g1.jpg GRAPHIC 284664
34 GRAPHIC g242555ex99_2p3g1.jpg GRAPHIC 357686
35 GRAPHIC g242555ex99_2p4g1.jpg GRAPHIC 332889
36 GRAPHIC g242555ex99_2p5g1.jpg GRAPHIC 298058
37 GRAPHIC g242555ex99_2p6g1.jpg GRAPHIC 365090
38 GRAPHIC g242555ex99_2p7g1.jpg GRAPHIC 258361
39 GRAPHIC g242555ex99_2p8g1.jpg GRAPHIC 237843
40 GRAPHIC g242555ex99_2p9g1.jpg GRAPHIC 301528
41 GRAPHIC g242555g0324123214353.jpg GRAPHIC 3922
  Complete submission text file 0001193125-22-084528.txt   13323497

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA lrmr-20220325.xsd EX-101.SCH 2863
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE lrmr-20220325_lab.xml EX-101.LAB 17995
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lrmr-20220325_pre.xml EX-101.PRE 11266
43 EXTRACTED XBRL INSTANCE DOCUMENT d242555d8k_htm.xml XML 3360
Mailing Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004
Business Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004 844-511-9056
Larimar Therapeutics, Inc. (Filer) CIK: 0001374690 (see all company filings)

IRS No.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36510 | Film No.: 22768211
SIC: 2834 Pharmaceutical Preparations